John Dyett

John Hathaway Dyett is the founder of Spectrix Therapeutics LLC, which was founded in 2016.
He is also the founder of Salem Partners LLC, which was founded in 1997.
At Salem Partners LLC, he currently holds the title of Co-Chief Executive Officer.
In his current positions, Mr. Dyett is the Co-Chief Executive Officer at Salem Partners Wealth Management LLC since 2004.
He is also an Independent Director at Medley Management, Inc. since 2020, and a Director at OncoNano Medicine, Inc. Mr. Dyett has held former positions as an Independent Non-Executive Director at Femasys, Inc. from 2017 to 2023.
He was also a Director at Sebacia, Inc., a Trustee at Middlesex School, and an Independent Trustee at Sierra Total Return Fund from 2016 to 2020.
Mr. Dyett completed his undergraduate degree at Harvard University.